ArticleFrontiers in immunology2026
Case Report: mNGS-negative
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Case description: A 73-year-old male patient with a history of chronic obstructive pulmonary disease (COPD), diabetes mellitus, hypertension, and cerebral infarction presented with abdominal pain and distension for 7 days and no bowel movement for 3 days. He was diagnosed with incomplete small bowel obstruction at an outside hospital and treated with fasting, enemas, meropenem, and methylprednisolone. He was subsequently transferred to our hospital due to acute lower respiratory tract infection. Chest radiography revealed bilateral diffuse infiltrates, and his condition rapidly deteriorated, requiring admission to the intensive care unit (ICU), endotracheal intubation, mechanical ventilation, and continuous renal replacement therapy (CRRT). Stool smear and retrospective sputum examination both identified larvae of Strongyloides stercoralis. However, mNGS of sputum and bronchoalveolar lavage fluid (BALF) obtained upon admission failed to detect any parasitic sequences. The patient was treated sequentially with albendazole and ivermectin, in combination with broad-spectrum antibacterial, antifungal, and antiviral therapy. He ultimately died on February 11, 2025, due to severe pneumonia, sepsis, and bone marrow suppression. Conclusion: For immunocompromised hosts with multiple risk factors, particularly those exposed to glucocorticoids, active parasitic microscopic examination of stool and respiratory secretions should be pursued when unexplained pulmonary infiltrates coexist with gastrointestinal symptoms, even in the setting of negative mNGS results, to avoid missed diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.